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ABSTRACT
Objective: The PEM Flex Solo II (Naviscan, Inc., San Diego, CA) is currently the
only commercially-available positron emission mammography (PEM) scanner. This
scanner does not apply corrections for count rate effects, attenuation or scatter during
image reconstruction, potentially affecting the quantitative accuracy of images. This work
measures the overall quantitative accuracy of the PEM Flex system, and determines the
contributions of error due to count rate effects, attenuation and scatter.
Materials and Methods: Gelatin phantoms were designed to simulate breasts of
different sizes (4 – 12 cm thick) with varying uniform background activity concentration
(0.007 – 0.5 μCi/cc), cysts and lesions (2:1, 5:1, 10:1 lesion-to-background ratios). The
overall error was calculated from ROI measurements in the phantoms with a clinically
relevant background activity concentration (0.065 μCi/cc). The error due to count rate
effects was determined by comparing the overall error at multiple background activity
concentrations to the error at 0.007 μCi/cc. A point source and cold gelatin phantoms
were used to assess the errors due to attenuation and scatter. The maximum pixel values
in gelatin and in air were compared to determine the effect of attenuation. Scatter was
evaluated by comparing the sum of all pixel values in gelatin and in air.
Results: The overall error in the background was found to be negative in
phantoms of all thicknesses, with the exception of the 4-cm thick phantoms (0%±7%),
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and it increased with thickness (-34%±6% for the 12-cm phantoms). All lesions exhibited
large negative error (-22% for the 2:1 lesions in the 4-cm phantom) which increased with
thickness and with lesion-to-background ratio (-85% for the 10:1 lesions in the 12-cm
phantoms). The error due to count rate in phantoms with 0.065 μCi/cc background was
negative (-23%±6% for 4-cm thickness) and decreased with thickness (-7%±7% for 12
cm). Attenuation was a substantial source of negative error and increased with thickness
(-51%±10% to -77% ±4% in 4 to 12 cm phantoms, respectively). Scatter contributed a
relatively constant amount of positive error (+23%±11%) for all thicknesses.
Conclusion: Applying corrections for count rate, attenuation and scatter will be
essential for the PEM Flex Solo II to be able to produce quantitatively accurate images.
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CHAPTER 1 – INTRODUCTION

Breast cancer is by far the most commonly diagnosed non-skin cancer in women
in the United States, and it is the second most fatal cancer in that population. It was
estimated that 192,370 new cases of breast cancer would be diagnosed in women in the
United States in 2009, and that 40,170 women would die from the disease(1)(1) (1). It has
been shown that the mortality due to breast cancer varies with stage at the time of
diagnosis (2). Between 1999 and 2006, the 5-year relative survival of patients diagnosed
with localized disease was 98%. This decreased to 84% in patients whose disease had
spread to regional lymph nodes, and to 23% in patients with metastatic disease. Early
detection of breast cancer is clearly vital to improving survival by allowing intervention
during earlier stages of disease. Additionally, early detection and accurate diagnosis may
afford patients more treatment options, such as breast conserving surgery (lumpectomy
vs. mastectomy) and less aggressive adjuvant chemotherapy (3).
Mammography is now the primary imaging modality for breast cancer screening
and its widespread use is responsible for reducing the mortality of breast cancer (4, 5).
As with any test, mammography has certain limitations, particularly lower sensitivity in
women with dense breasts and low positive predictive value (PPV) overall (6). Other
disadvantages of mammography include exposure to ionizing radiation and patient
discomfort. Using adjunct imaging modalities (e.g. ultrasound, MRI and functional
imaging) in combination with mammography improves the sensitivity of breast cancer
screening compared with mammography alone (7, 8). The benefits and limitations of
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mammography and some common adjunctive modalities for imaging breast cancer are
discussed below.

Mammography
Mammography is the application of projection radiography to breast imaging. The
radiographic appearance of normal breast tissue and cancers in the breast was first
studied ex vivo in the 1910s (9) and clinical investigations with mammography in the
United States were reported in 1930 (10). The diagnostic value of mammography was not
recognized until the early 1950s but still was not used by most radiologists into the 1960s
because of technical difficulties and limitations ,in addition to its lack of reliability and
reproducibility (11). Owing to advances in mammography since then, multiple large,
randomized clinical trials have shown that mammography screening substantially reduces
the mortality of breast cancer through early detection and intervention (4, 5). Such results
inspired the American Cancer Society (ACS) to recommend that women who are over the
age of 40 years and have an average risk of developing breast cancer receive annual
screening mammograms (3).
Mammography has become the primary imaging modality for breast cancer
screening because of its high sensitivity, and it plays an important role in diagnosis.
Although the sensitivity is high overall, it varies with breast compositions and it is lower
in dense breasts (6, 12). Digital mammography has slightly better sensitivity than filmscreen mammography in certain subgroups, particularly women with heterogeneously
dense or very dense breasts (13, 14). Regardless of detector type, one weakness of
mammography is the 2D nature of projection imaging, because overlying tissue can
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obscure or mask lesions. Also, the specificity and PPV are low (4, 6), leading to many
unnecessary diagnostic procedures such as additional mammographic views, fine needle
aspirations or ultrasound-guided core biopsies. Fortunately, there are other diagnostic
modalities that do not share the same limitations as mammography.

Breast Ultrasound
With respect to breast imaging, one advantage of ultrasound (US) is that lesions
are not obscured by overlying tissue. Also, US does not expose the patient to ionizing
radiation. US is commonly used to characterize suspicious lesions found with
mammography, or when palpable masses are not visible in mammograms (15). US can
easily differentiate between fluid-filled cysts and solid nodules (16) and using strict
criteria such as the BI-RADS lexicon has allowed some solid nodules to be classified as
benign or malignant with US (17, 18). If lesions cannot be ruled out as benign, US is also
useful for guiding needle core biopsies without unnecessarily exposing patients to
ionizing radiation. In addition to its roles in diagnosis and follow-up, US could be a
useful adjunct to mammography for breast cancer screening, particularly in dense breasts
(6, 7). While US cannot easily detect microcalcifications indicative of DCIS (19), early
stage, node-negative cancers have been discovered with US (20-24). Thus, the use of
adjunct US for breast cancer screening increases the sensitivity of detecting breast cancer
to earlier stage cancers than mammography alone. Whereas the sensitivity is greater, the
reported specificity and positive predictive value (PPV) are often lower because many of
the additional findings are benign. The low specificity and high false positive rate are two
reasons US screening has not been widely adopted as a standard procedure.
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Breast MRI
Magnetic resonance imaging (MRI) can acquire volumetric images, eliminating
the problem of overlying tissue. Ionizing radiation is also not of concern in MRI. Like
US, MRI is commonly used to follow up on suspicious mammographic findings. Breast
MRI is useful for determining whether diagnosed breast cancers have spread beyond
what is indicated with mammography or US, e.g. multifocal or multicentric disease,
nodal involvement or chest wall invasion (15). Breast MRI can also detect cancers which
are mammographically and clinically occult (25) and it may used to guide biopsies of
breast lesions (26). Due to its high sensitivity, breast MRI is suggested by the ACR as an
adjunct to mammography for screening of certain high-risk women (3). However, many
benign lesions and even normal breast tissue can be mistaken for cancer, leading to very
low specificity of this modality (25, 27).

Functional Breast Imaging
Functional imaging is yet another tool available for imaging breast cancer with
the advantage of supplementing the anatomical imaging modalities with information
about the disease state. Overlying tissue is less likely to obscure lesions, though it might
reduce the signal. Conventional nuclear medicine modalities vary in their sensitivities to
breast cancer due to the resolution of conventional systems, but they have higher
specificity than anatomical modalities (8). High-resolution imaging devices are under
investigation and have improved detection sensitivity in small tumors.
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Scintimammography
Scintimammography is a functional imaging technique that commonly uses
99m

Tc-methoxyisobutylisonitrile (99mTc-sestamibi) to image breast cancer (8).

99m

Tc-

sestamibi concentrates in breast cancers (28) due to an increase in blood flow, number of
mitochondria, membrane hyperpolarization in the tumor or expression of the multidrug
resistance gene (29-32).

Patients are imaged prone with the breast pendant and

uncompressed (8). Scintimammography has good overall sensitivity and specificity to
breast cancer (33, 34). The resolution of conventional gamma cameras limits the
sensitivity of scintimammography to tumors smaller than 5 mm and it is more useful for
imaging palpable primary breast cancers than non-palpable ones (28).

Molecular Breast Imaging/Breast-Specific Gamma Imaging
Molecular Breast Imaging (MBI) and Breast-Specific Gamma Imaging (BSGI)
acquire images of

99m

Tc-sestamibi with small gamma cameras dedicated to breast

imaging (35). These systems use mild compression to immobilize the breast and decrease
the amount of attenuating tissue between lesions and the detector, can be positioned much
closer to the breast and have much better spatial resolution, thus offering better sensitivity
to small tumors than conventional gamma cameras. Studies at the Mayo clinic have
shown that MBI has similar sensitivity to breast MRI (35). It also detected 2- to 3-times
more cancers in dense breasts than mammography, and with slightly better specificity.
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Breast PET
Another functional imaging modality is positron emission tomography (PET),
which has the advantage of quantifying activity concentration. PET is most commonly
performed with the radiopharmaceutical 2-[18F]-fluoro-2-deoxy-D-glucose (FDG), a
glucose analog which is trapped in metabolically active cells (36). Cancer cells typically
have a higher metabolic rate than normal tissue, resulting in greater FDG uptake in
malignancies. The quantitative nature of PET allows accurate diagnosis or staging of
advanced breast cancers (37, 38) as well as monitoring of treatment response (39, 40).
The resolution of conventional scanners limits the sensitivity of PET to tumors greater
than 5-10 mm.

Positron Emission Mammography
To overcome the limitations of whole body PET scanners for imaging breast
cancer, Thompson, Murth, Weinberg and Mako (41) designed a dedicated scanner with a
more optimal geometry for high detector efficiency and high resolution. The original
positron emission mammography (PEM) scanner used dual-head opposing planar
coincidence detectors between which a breast could be immobilized with mild
compression. Several PEM systems with variations of Thompson’s configuration have
been investigated since at least the early 2000s (42-47).
Using dedicated detectors very close to or in contact with the breast being imaged
is extremely advantageous in two ways. First, these systems have greater geometric
efficiency due to the large solid angle subtended by the detectors. Thus, the detection
efficiency is on the order of two orders of magnitude greater than whole body 3D PET
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scanners (48). The compression used by most systems reduces attenuation, which also
increases the detection efficiency. Second, the small distance between the detectors
reduces blurring due to noncolinearity to less than 0.25 mm—much smaller than a
pixel—for even a 10 cm thick breast (49). Employing small crystals in this detector
configuration further improves the resolution over whole-body PET scanners (< 2.5 mm
vs. > 4 mm FWHM) (7, 41, 43, 45, 50).
These impressive performance characteristics allow PEM to detect breast cancer
earlier than conventional PET, including in situ cancers (45, 50, 51). In addition to high
sensitivity, PEM has high specificity (50, 52). Other benefits of PEM include correlation
with x-ray mammograms by incorporating both imaging devices into one system, as well
as image-guided biopsies (53). While PEM is very useful for detecting breast cancer,
accurate diagnosis and staging with PEM will require systems to accurately quantify
radiotracer uptake.
There is currently only one commercially-available PEM scanner, the PEM Flex
Solo II (Naviscan, Inc., San Diego, CA). This system is described in Chapter 2, but
briefly, it uses opposing planar coincidence detectors between which a patient’s breast is
immobilized during scans with mild compression (48, 54). Corrections such as for dead
time, randoms, attenuation and scatter are not currently applied on the PEM Flex. While
this scanner is very good at detecting disease (50), accurate diagnosis and staging based
on radiotracer uptake will require the system to be quantitatively accurate.
The purpose of this thesis is to evaluate the quantitative accuracy of the PEM Flex
Solo II, and to determine the contributions of error from count rate effects, attenuation
and scatter. As a benchmark for accuracy, the Positron Emission Response Criteria In
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Solid Tumors (PERCIST) suggests that treatment response of a tumor is indicated by
PET if SUV decreases by 30% (55).

Figure 1.1: The Naviscan PEM Flex Solo II positron
emission mammography scanner (Left). The detector
heads inside the compression paddles (Right).

Hypothesis and Specific Aims
Hypothesis: The total quantitative error of images acquired with the PEM Flex
Solo II is greater than 30%, due in part to count rate effects, attenuation and scatter.
This hypothesis was tested using the following specific aims:
1) Measure the total quantitative error in breast phantoms of multiple sizes, with
uniform background and embedded cysts and lesions of different lesion-tobackground ratios
2) Determine the error due to count rate effects
3) Determine the error due to attenuation
4) Determine the error due to scatter
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CHAPTER 2 – MATERIALS AND METHODS

PEM Flex Solo II

System Configuration
The PEM Flex Solo II scanner utilizes a scanning, dual-headed coincidence
detector to produce limited-angle tomographic (LAT) images. The detectors are mounted
on an articulating arm which allows images to be acquired in any orientation, e.g.
craniocaudal and mediolateral. The lower (support) paddle is fixed to the arm while the
upper (compression) paddle is adjustable to provide mild compression (15 lbs of force)
and can be moved up to 20 cm from the support paddle.
The detectors are housed inside 16.8 × 6.2 × 5.5 cm3 enclosures which scan
synchronously across the FOV in the x-direction during acquisitions. The enclosure is
light-tight and EMI-tight. Additionally, the enclosure is 95% tungsten on 5 sides to shield
the detectors from radiation outside the FOV. The entrance window is 1-m thick
aluminum to maximize transmission of annihilation photons from within the FOV. Each
detector head houses a 2 × 6 matrix of detector modules, each of which comprises a
crystal array, a reflective light guide and a position-sensitive photomultiplier tube
(PSPMT). Individual crystals (2 × 2 × 12 cm3) of LYSO are packed in 13 × 13 arrays
with a crystal pitch of 2.1 mm.

Data Flow
During acquisition, PMT signals are tested for coincidence with a coincidence
timing window of 6 ns. List data for coincident events include a time stamp and 32 ADC
9

values. A delayed coincidence window of about 100 ns is used to estimate random
events, which are written to their own list file but not used to correct for randoms.
Table 2.1: Typical Clinical PEM Protocol
Acquisition
Views
Mediolateral and craniocaudal of
affected breast(s)
Field-of-view (x-y plane)
24 × 16.8 cm2 (maximum)
FOV (z-direction)
Patient dependent (up to 19 cm)
Compression force
≤ 15 lbs
Scan duration
Variable (typically 10 min)
Reconstruction
Coincidence timing window
6 ns
Energy window
350 – 750 keV
Acceptance angle
25 crystals. Angle varies with
paddle separation
Algorithm
Iterative 3D Maximum Likelihood
Expectation Maximization
Number of iterations
5
Corrections
Detector normalization, geometric
efficiency. NO corrections for
randoms, dead-time, attenuation,
scatter or intrascan decay
Reconstruction time
Depends on number of counts
(typically < 15 min)
Images
Image matrix
136 × 200
Pixel size
1.2 × 1.2 mm2
Resolution
2.4 mm FWHM
Number of slices
12
Slice thickness
1/12th detector separation
Units
μCi/cc or PEM Uptake Value
(PUV)

The ADC values are used subsequently to identify the coordinates and energy of
each event during rebinning, at which point an energy window is applied. The default
lower and upper level discriminators (LLD and ULD) are 350 and 750 keV, respectively.
Coincident events within the energy window are rebinned into a 4D histogram and
written to a decode file which is used for reconstruction.
10

Images are reconstructed from data in the decode file using an iterative, 3D
maximum-likelihood expectation maximization (MLEM) algorithm. In standard clinical
mode 5 iterations are used to reconstruct 24 evenly-spaced image planes. The slice
thickness is equal to 1/24th of the detector separation. The maximum acceptance angle is
determined by crystal separation and detector separation. In the x-direction the crystal
separation is physically limited by the width of the detector heads (5.5 cm, or 26 crystal).
There are 78 crystals in the y-direction, but the default constraint on acceptance angle is
the same as in the x-direction.
The PEM Flex system currently applies no corrections for count rate effects,
attenuation or scatter. Corrections which are performed are detector normalization and
decay correction to injection time (only for PUV images). No corrections are applied for
intrascan decay, which is 8.7% over 10 minutes for 18F.
Rebinning and reconstruction begin during acquisition and partially reconstructed
images are displayed. List data are rebinned in approximately one-minute ―chunks‖ from
which images are reconstructed independently of other chunks. After each chunk is
reconstructed, the new image is merged with all previously reconstructed chunks.

System Characterization
Measurements characterizing the system performance have been reported by
others (45), including the manufacturer (48). With the paddles separated by 9 cm, the
resolution was about 2.4 mm in-plane and more than 9 mm in the direction perpendicular
to the detectors. The total sensitivity was found to be 0.16 cps/Bq using a point source inair with the paddle separation set to 5 cm. The scatter fraction using a line source in a rat
phantom was 13%. Uniformity in images of a 5-ml intravenous saline bag with 18F-FDG
11

was reported to be 6% by one group (45). Linearity and NECR were also evaluated as
well as recovery coefficients for objects as small as 1 mm.

Specific Aim 1: Total Quantitative Error

Gelatin Breast Phantoms
To measure the overall quantitative error of the PEM Flex Solo II (described in
the Introduction), phantoms were needed which satisfied several criteria. While the SUV
in breasts varies with tissue type (56), a uniform background activity concentration
(hereafter referred to as background) is more reproducible than a heterogeneous
distribution and it reduces measurement uncertainty. Further, the actual background in
phantoms should be representative of that observed clinically. Breast cancers exhibit a
range of lesion-to-background ratios (LBR) and cysts with no uptake may also be present,
thus multiple LBRs and cysts needed to be simulated. The linear attenuation and scatter
coefficients of the phantoms needed to be comparable to breast tissue at 511 keV. In
addition to the radiological properties of the material, the size and shape of an object may
influence how much attenuation and scatter contribute to the error. Thus, a range of sizes
was needed as well as a shape similar to that of a breast under mild compression between
the detector paddles.
An alternative to water which has previously been used to construct PEM
phantoms is gelatin (44, 57). Gelatin is well-suited for breast phantoms in part because,
like water, the background and size are arbitrary. In addition, gelatin can be made in an
arbitrary shape, and simulated lesions and cysts can be positioned anywhere inside the
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phantoms without introducing other materials such as hollow plastic spheres. Also, as
noted below, the linear attenuation coefficient of the gelatin was within 1.5% of those of
water at diagnostic energies. This difference should be negligible at 511 keV, thus gelatin
was assumed to be radiologically similar to breast tissue at 511 keV (Table 2.2).

Table 2.2: Linear Attenuation Coefficients of Water and
Breast Tissue
Total
Compton
-1
Material
μ (cm )
μ (cm-1)
Breast Tissue (ICRU-44)
0.0973
0.0971
Water
0.0959
0.0956
Percent Difference
-1.4%
-1.5%
The elemental composition and density (1.02 g/cm3) of
breast tissue comprising 50% adipose and 50% glandular
tissue reported in ICRU 44 were entered into XCOM (58)
to calculate the mass attenuation and incoherent (Compton)
scattering coefficients, from which the linear coefficients
were calculated. The coefficients for water were also
calculated in XCOM using the elemental composition of
H2O.

The phantoms used to measure the overall quantitative error comprised stackable,
semicircular slabs of gelatin with uniform background and gelatin cysts and lesions. The
background activity concentration was chosen to be 0.065 μCi/cc (2590 Bq/ml), to
approximate the background in normal breast tissue during conventional PET scans
(Table 2.3). Each phantom contained either two cysts and two 2:1 lesions, or two 5:1 and
two 10:1 lesions (Figure 2.1a) fully embedded in the middle layer, for a total of four
objects in each phantom. The objects were spaced to minimize the signal each would
contribute to measurements in the others and in the uniform background. The slabs were
easily reproducible, could be stacked to the desired heights (4, 6, 8, 10 and 12 cm), and
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the profile of each phantom resembled the shape of a breast compressed between the
detectors (Figure 2.1b).

Table 2.3: Estimated Background Activity Concentration
in Normal Breast Tissue
Injected Dose (59)

15 mCi

Patient Mass (60)

74 kg

Uptake Time (55)

60 min

SUV (61)

0.49

Activity Background Concentration

0.067

A

B

C

Figure 2.1: Gelatin breast phantoms. A) Simulated lesions
and cysts were completely embedded in the middle slab of
each phantom. B) Slabs were stacked to 4, 6, 8, 10 and 12
cm and resembled a breast compressed between the
detector paddles. C) An assembled phantom positioned on
the scanner.
To make the phantoms, first gelatin mix (Kroger, Cincinnati, OH) was dissolved
per the manufacturer’s instructions in enough water to make the background lesions and
cysts for one phantom. The objects to be embedded—either cysts and 2:1 lesions, or 5:1
and 10:1 lesions—were made first with 100 ml of the gelatin solution for each type of
object. Food dye was added to distinguish the objects from each other and activity was
added to yield the necessary LBRs. The solution for each type of object was poured into
separate 10 × 1.5 cm Petri dishes (BD Biosciences, Bedford, MA) and allowed to solidify
in a freezer at -20°C. The dishes were removed after about 10 minutes, before the gelatin
14

froze. The end of a 60-cc syringe was cut off and the edge around the open end was
sharpened to be able to cut 3-cm diameter cylinders out of each dish. At 1.5 cm tall, the
lesions and cysts were sufficiently large to avoid partial volume effects, even in the
largest phantoms. Two of each type of object were positioned in a 20-cm diameter,
disposable plastic plate (Kroger, Cincinnati, OH). The plates were clear so the objects
could be placed according to a printed template underneath the plate. The arrangement
was intended to allow multiple measurements for each type of object in each phantom
while minimizing the signal the lesions would contribute to each other and to the
background.
18F-FDG was then added to the rest of the gelatin solution and mixed well to
yield a uniform background activity concentration (AC). The background gelatin was
poured into several disposable plastic plates and allowed to solidify in a freezer. The
plates were removed after about 20 minutes, before the gelatin froze. The remainder of
the background gelatin was allowed to cool to room temperature before pouring it into
the plate with the lesions and cysts, which were kept in a refrigerator in the meantime.
This prevented the objects from melting and dissolving into the background. The
background gelatin was deep enough to cover the lesions and cysts so they were fully
embedded in the slab. As mentioned, each phantom contained for objects—either two
cysts and two 2:1 lesions, or two 5:1 and two 10:1 lesions.
Once solid, the slabs of gelatin were cut into two pieces. The bottoms of the plates
were flat and the edges were sloped such that the profile of the assembled phantoms
resembled a breast compressed between the detector paddles (Figure 2.1b). Prior to
scanning the phantoms, each slab was placed in a 1-gallon Ziploc® bag (S.C. Johnson &
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Son, Inc., Racine, WI) to facilitate handling and to avoid radioactive contamination in
case any gelatin broke off.
To confirm that the phantoms were radiologically similar to water, the average CT
number was measured in 3 separate 10-cm phantoms. Each phantom was centered on the
patient table of a GE Discovery PET/CT scanner (Waukesha, WI) with the slabs aligned
transaxially. CT scans (120 kV, 300 mA 3.75 mm image thickness, pitch = 1, standard
reconstruction algorithm) were acquired and a large ROI drawn in the middle layer of
each. The average pixel value was approximately 15 Hounsfield Units, representative of a
1.5% greater attenuation coefficient than water for a diagnostic beam. It is expected that
this difference is negligible at 511 keV so the gelatin phantoms were assumed to be
radiologically similar to breast tissue at that energy.

Phantom Scans
Three phantoms of each thickness (4, 6, 8, 10 and 12 cm) were scanned on the
PEM Flex system following a schedule which was intended to be efficient. Phantoms of
multiple thicknesses were assembled from each batch of gelatin and scanned serially in
order of decreasing thickness. For instance, 10-, 8- and 6-cm thick phantoms were made
from a single batch of gelatin. Similarly, 12-cm and 4-cm thick phantoms were made
from one batch of gelatin. Thus, a total of 30 scans (3 scans × 5 thicknesses × 2 sets of
objects) were acquired with 6 batches of gelatin. Due to interscan decay, the background
activity of each phantom was within 15% of the nominal background (0.065 μCi/cc).
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Calculation of Total Quantitative Error
Images were reconstructed with the standard clinical protocol (Table 2.1) and
evaluated on the scanner GUI in units of μCi/cc. Region of interest (ROI) measurements
were made in the plane at the level of the lesions and cysts. The mean pixel values were
measured in 1-cm2 ROIs in the uniform region of the background and in the cysts. A large
ROI was drawn around each lesion and the maximum pixel value measured. The
maximum pixel value was chosen to evaluate the lesion error because the maximum
standardized uptake value (SUV) is the most commonly reported metric to assess tumors
with PET (55). The error in the background and lesions was calculated as the percent
difference between the ROI measurements and the true values (Equation 2.1)
%Error = 100×(ACROI – ACTrue)/ACTrue

2.1

where ACROI is either the mean pixel value in the background or the maximum
pixel value in the lesions and ACTrue is the respective known activity concentration in
each.
The error in the cysts could not be calculated using Equation 2.1 because dividing
by the true activity concentration (0 μCi/cc) would be undefined. Instead, the contrast
error in the cysts (Equation 2.2) was calculated from the mean pixel value in a 1-cm2
ROI.
%Contrast ErrorCysts = 100×[(ROIBkg– ROICyst)/True Bkg - 1]

2.2

where ROIBkg is the measured background, ROICysts is the mean pixel value in each cyst,
and True Bkg is the known activity concentration in the background.
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Specific aim 2: Error due to Count Rate

To evaluate the count rate behavior of conventional PET scanners, phantoms are
commonly made with very high uniform background activity of a short-lived
radioisotope (e.g.
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F) and scanned over the course of several half-lives. At very low

count rates the net count rate is approximately equal to the true event rate because dead
time and randoms are minimal. Therefore the ideal true count rate at all activities is
estimated by linear extrapolation from the net count rates for the lowest amounts of
activity (62).
This approach was adopted to measure the error in images due to count rate. The
error was measured in images of breast phantoms with multiple levels of radioactivity.
The error in the lowest activity phantoms was used as a reference to calculate the error
contributed by count rate alone at higher background activity concentrations.

Phantom Scans
The phantoms made to measure the total quantitative error (Specific Aim 1) were
also used to measure the error due to count rate. The phantoms which had uniform
background AC of 0.065 μCi/cc at the time of the first scan and were scanned multiple
times while they decayed to 0.007 μCi/cc. It was subsequently decided that the error in
phantoms with higher backgrounds should be evaluated, so one additional phantom of
each thickness was made with an initial background of 0.5 μCi/cc and scanned multiple
times until they had decayed to 0.065 μCi/cc. The actual background activity
concentrations at the times of the scans were 0.5, 0.25, 0.125, 0.065, 0.044, 0.032, 0.010
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and 0.007 μCi/cc. A total of 190 scans were acquired for this specific aim, including the
30 scans acquired to evaluate the total quantitative error.

Calculation of Error
The error in the background and lesions was calculated as described for Specific
Aim 1 for each phantom at every background activity concentration. The error at the
lowest concentration (0.007 μCi/cc) was assumed to have minimal contribution from
count rate effects and was used for comparison with the error at higher activities. The
difference in error in each phantom at high background AC and 0.007 μCi/cc background
AC was assumed to be due to count rate effects at each activity level. A surface plot was
generated showing how the error due to count rate varies with background AC and
phantom thickness. Additionally, the error due to count rate in lesions was plotted for
phantoms with 0.065 μCi/cc background AC.
To validate the results obtained with phantoms, an additional experiment was
performed whereby the effect of count rate was evaluated in the absence of attenuation
and scatter. A thin film of gelatin was prepared with 18F-FDG in a 15-cm diameter Petri
dish and scanned multiple times while it decayed. The gelatin was centered in the FOV
halfway between the paddles which were separated by 4 cm for each scan. The initial
activity concentration (6.8 μCi/cc) was chosen to yield the same count rate as was
observed in the 4-cm phantoms with 0.065 μCi/cc background. During each subsequent
scan, the count rate from the film was equal to the count rate during one of the scans of
the 4-cm phantoms. A large ROI was drawn in images of the film and the mean pixel
values at each count rate were normalized to the mean pixel value measured at the lowest
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count rate. For comparison, the mean pixel values in the background of 4-cm phantoms at
each activity concentration were also normalized to the mean in the phantoms at the
lowest activity. The relative signals of the film and phantoms were plotted against count
rate and compared. The uncertainty of the film measurements was estimated from the
standard deviations of pixel values in each ROI. The uncertainty of the phantom
measurements was estimated from the standard deviations of the mean ROI
measurements in the phantoms.

Specific Aim 3: Error due to Attenuation
One of the most important corrections for accurate quantitation with PET is for
attenuation. Prior to hybrid PET/CT scanners, coincidence transmission scans were
commonly used for this purpose. The technique uses two sinograms which are acquired
while a positron-emitting rod source (e.g. Germanium-68) is rotated around the FOV
(62). A reference, or blank, sinogram is acquired with nothing in the FOV and a
transmission sinogram is acquired with the patient in the FOV. Only coincidence events
which are collinear with the known location of the line source are counted in either scan
because all others must be due to randoms or scatter. The attenuation along each LOR is
calculated by comparing the count rates in the transmission sinogram to the count rates in
the reference sinogram. A similar approach was used to measure the error due to
attenuation on the PEM Flex system. However, because the goal of this work was to
measure the error in images, measurements were based on reconstructed images rather
than projection data.
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Point Source Transmission Scans
Blank and transmission scans of a point source were acquired to evaluate the error
due to attenuation in gelatin breast phantoms of multiple sizes. A low activity point
source was rigidly attached to the center of the bottom paddle and scanned with cold
(non-radioactive) gelatin stacked on top of it and again with nothing in the FOV. It was
assumed that the differences in the maximum pixel values in images acquired in gel and
in air at the same paddle separation were primarily due to attenuation and source activity,
as argued in the Discussion. The maximum pixel values were normalized to activity and
compared to calculate the error due to attenuation.
A point source of approximately 20 μCi was centered on the bottom paddle of the
PEM Flex scanner and taped in place (Figure 2.2). The low activity was chosen to
minimize dead time and randoms. Even though the point source was smaller than a pixel
(1.2 × 1.2 × 1.2 mm3), partial volume effects (PVE) were not considered important
because only relative measurements were being made. Further, it was assumed that PVE
would be the same for scans acquired with the same detector separation as long as the
source did not move with respect to the paddles between scans.
A series of scans was acquired with cold gelatin breast phantoms of different
thicknesses assembled on top of the source. The phantom scans were acquired in order of
decreasing thickness (12, 10, 8, 6 and 4 cm) in order to help maintain similar count rates
during all scans. Data were acquired for 10 minutes while the detectors translated across
the entire FOV with the paddles set to the thickness of each phantom. Air scans were
subsequently performed with the detector paddles separated by each of the same
distances, in order of decreasing separation. The source was allowed to decay before the
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first air scan to ensure the count rate in air was similar to that in the gel scans. This
experiment was performed three times for a total 30 separate scans.
Transmission Scan

Reference Scan

Detector
Heads

18

F-FDG Point
Source

4 – 12 cm

Cold Gelatin

Figure 2.2: Reference (left) and transmission (right) scans of a point source for
measuring the error due to attenuation.

Calculation of Error
Images were reconstructed with the standard clinical protocol (Table 2.1) and
evaluated on the scanner console in units of μCi/cc. The maximum pixel value in the
plane corresponding to the point source was measured for each set of images. The
maxima were normalized to the source activity at the time of each scan because images
displayed in units of μCi/cc are not decay-corrected. For each phantom, the error due to
attenuation was calculated from the percent difference was calculated between the
normalized maxima in gel and in air at the same paddle separation (Equation 2.3). The
results from three experiments were averaged and plotted versus thickness.
%ErrorAttenuation = 100×(Max’Gel – Max’Air)/Max’Air

2.3
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Specific Aim 4: Error due to Scatter
A method for evaluating scatter in sinograms (63) was modified and used used to
measure the error due to scatter in images. Their setup involved a line source which was
scanned in air and in a water-filled phantom. Three sinograms were produced: gair from
the scan in air; gwater from the scan in water; and gatten, which was the calculated
attenuation introduced by the water for each projection bin. The total counts in the water
were found by integrating gwater and the true counts in water were estimated by
integrating the product gatten×gair. The estimated true counts were subtracted from the
total counts in water, the difference being the counts due to scatter. The scatter fraction
was the ratio of this difference and the total counts from the water scan (Equation 2.4):
SF = [(Σgwater – Σgair×gatten)/Σgwater]

2.4

The method used by Bailey and Meikle was modified and applied to images from
the PEM Flex system. First, a point source was used instead of a line source. The source
was scanned with and without gelatin phantoms in the FOV. Second, rather than
integrating projection data to calculate counts, pixel values were summed to calculate the
total activity within the image volumes. The sum of pixel values with gelatin were
compared to the sum without, and the error due scatter was estimated.

Point Source Transmission Scans
The error due to scatter was measured in the same image sets as were used for
calculating the attenuation error. To reiterate, a point source was centered on the bottom
paddle and scanned with 4 – 12 cm of cold gelatin on top of it. The paddles were set to
the thickness of each phantom for the scans. Scans without gelatin were acquired at each
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of the same paddle separations.

Calculation of Error
An ROI was drawn around the entire FOV in one image from each scan and
propagated to all slices. The scanner console reports the sum of values in an ROI as the
total activity (μCi) in the region (the product of activity concentration in μCi/cc and ROI
volume in cm3). The total activity measured in each image volume was normalized to the
actual activity of the source at the time of each scan. The total activity (or signal) in
gelatin was assumed to differ from that in air for two primary reasons: attenuation and
scatter. The signal expected due to attenuation was estimated by artificially attenuating
the total activity measured in air at the same paddle separation. While Bailey and Meikle
calculated the attenuation from the path length of water in each bin of their water
sinograms, the effective attenuation for this work was taken from the results from the
attenuation measurements described in Specific Aim 3. The signal due to scatter was
calculated by taking the difference between the total signal in gelatin and the estimated
signal due to attenuation at the same thickness. The error due to scatter was determined
from the ratio of the signal due to scatter and the total activity in air (Equation 2.5),
%ErrorScatter = 100×(TotalGel – TotalAir×Attenuation)/TotalAir

2.5

where TotalGel is the total activity measured in gelatin, TotalAir is the total activity
measured in air and Attenuation is the relative signal expected due to attenuation.
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CHAPTER 3: RESULTS

Specific Aim 1: Total Quantitative Error
The total quantitative error in the uniform background and embedded lesions in 4
– 12 cm thick gelatin breast phantoms is plotted in Figure 3.1 where the error bars
indicate 1 standard deviation of three measurements. The error in the uniform background
was negative for virtually all thicknesses, with the exception of the 4-cm thick phantom
in which the average background error was 0±7%. The background error increased (i.e.,
became more negative) with thickness.
The error in lesions was negative for all thicknesses and LBRs and it was much
greater than the background error. As in the background, the error in the lesions increased
with phantom thickness and it also increased non-linearly with LBR. The contrast error of
the cysts was greater contrast than the error in any of the lesions.
PEM images from gelatin breast phantoms of each thickness are displayed in
Figure 3.2 with the same window width and level. The signal in the background, lesions
and cysts decreased with thickness, as well as the contrast of the lesions and cysts. A
broad band of enhancement is visible along the chest wall edge of the FOV (top) in the 4
cm phantoms and it decreases in severity with phantom thickness. This artifact is also
visible but much less conspicuous in clinical images of breast compressed to 6 cm or less.
The manufacturer is aware of the artifact and does not have an explanation or a correction
for it. The 5:1 and 10:1 lesions in a uniform background of 0.065 μCi/cc are visible in all
12 images from one 12-cm thick phantom (Figure 3.3). The pixels near the edges of the
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FOV are very noisy compared to the central FOV, particularly the first row of pixels
along the chest wall edge (Figures 3.2 and 3.3).

%Error

Total Quantitative Error

Phantom Thickness (cm)
Figure 3.1: The total quantitative error in images of 4, 6, 8, 10 and 12cm thick gelatin breast phantoms with simulated cysts and lesions of
different lesion-to-background ratios (2:1, 5:1, 10:1).

Figure 3.2: Images of lesions and cysts in gelatin breast phantoms of each thickness
with 0.065 μCi/cc background AC. Images are displayed with the same window
width and level (14,000/7,000 Bq/ml).
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Run 1167
Figure 3.3: All 12 PEM images (1-cm thick) of a 12-cm thick phantom with 5:1 and
10:1 lesions in a uniform background AC of 0.065 μCi/cc.

Specific Aim 2: Error due to Count Rate
A surface plot of the count rate error in the uniform background (Figure 3.4)
shows that the count rate contributed large negative errors for virtually all activity levels
evaluated. The error due to count rate increased with background activity concentration,
and decreased with thickness.
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%Error

Error due to Count Rate

Background
(μCi/cc)

Thickness
(cm)

Figure 3.4: Error due to count rate in uniform background of phantoms with varying
background AC and thickness.
The count rate error in lesions of the phantoms with 0.065 μCi/cc background is
also plotted for comparison with the count rate error in the uniform background (Figure
3.5). At this activity the 2:1 lesions had more error due to count rate than the background
for some phantom thicknesses but it did not change monotonically. The count rate error in
lesions decreased with respect to thickness in the 5:1, and remained relatively constant
with thickness in the 10:1 lesions. The count rate error in lesions decreased non-linearly
with LBR for all thicknesses.
The mean signal in images of a thin film of gelatin scanned multiple times as it
decayed was normalized to the signal at the lowest activity and plotted as a function of
count rate. The mean signal in the background of 4-cm phantoms was also normalized to
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the signal at the lowest activity and plotted. The normalized signal in the film follows the
same trend with count rate as the normalized signal in 4-cm phantoms.

%Error

Error due to Count Rate
(0.065 μCi/cc background AC)

Phantom Thickness (cm)
Figure 3.5: Error due to count rate in lesions and background of
phantoms with 0.065 μCi/cc background AC

Specific Aim 3: Error due to Attenuation
The error due to attenuation is plotted in Figure 3.6 with error bars indicating the
standard deviation of three measurements. For comparison, the black curve is the
percentage of signal loss expected due to narrow-beam attenuation of 511 keV photons in
water (μ = 0.096 cm-1).
The error due to attenuation was negative and large for all thicknesses, and it
increased with thickness (from -51±10% to -77±4% at 4 and 12 cm, respectively). The
measured error was greater than the relative signal loss calculated for narrow-beam
attenuation.
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Error due to Attenuation

%Error

y = 100×(1 – e-μD)

Measured
Error
Narrow-beam
Signal Loss

Phantom Thickness (cm)
Figure 3.6: The measured error due to attenuation with the percent signal loss expected
due to attenuation of 511 keV photons in the given thicknesses (D) of water.

Specific Aim 4:Error due to Scatter
The total activity measured in gelatin was greater than what would be measured
from attenuated true LORs alone. The additional activity due to scatter was found to be a
relatively constant fraction of the total activity in air (Figure 3.7).
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%Error

Error due to Scatter

Phantom Thickness (cm)
Figure 3.7: Error due to scatter. Error bars indicate the standard deviation of three
independent measurements.
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CHAPTER 4 – DISCUSSION AND CONCLUSIONS

As is true for conventional PET, PEM has many competing sources of
quantitative error including, but not limited to, count rate effects (e.g. dead-time, random
coincidences, pulse pile-up), attenuation and scattered photons. The results suggest
additional sources of error.

Specific Aim 1: Total Quantitative Error
The competitive nature of the individual errors resulted in good agreement (0±7%
error) between the measured and known activity concentration in the background of 4-cm
phantoms (Figure 3.1). The background error in thicker phantoms was negative and
increased with thickness (Figure 3.1), as is visually evident in Figure 3.2. This trend is
consistent with the fact that signal decreases due to attenuation with increasing thickness,
thus contributing negatively to the total error. Attenuation is not corrected for on the PEM
Flex Solo II and its impact on images is evaluated in Specific Aim 3.
The error in the lesions of all LBRs is greater than the error in the background and
it increases with LBR. This behavior indicates an additional source of quantitative error
which is not apparent in the uniform background: limited-angle tomography (LAT). The
effect of LAT on quantitation has been calculated by Murthy, Aznar, Thompson, Loutfi,
Lisbona and Gagnon (64) and their formulation (Equation 4.1) can be rearranged to show
that the error in measured lesion AC is inversely proportional to LBR.
LBR M easured

LBRTrue

d
D

D

d

4.1

D

where LBRMeasured is the measured LBR, LBRTrue is the true LBR, d is the lesion
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dimension perpendicular to the detectors and D is the phantom thickness.
In LAT, many projection angles are missing and cannot be used to constrain
activity along existing LORs. Thus, LAT mispositions signal along LORs, essentially
smearing objects in images perpendicularly to the detectors. The signal lost from lesions,
which is represented by the first term in Equation 4.1, is misplaced in other planes,
making the lesions visible throughout most or all of the other image planes (Figure 3.3).
This loss of signal from the lesions explains why the error is greater in lesions than in the
background. Another interesting aspect of the lesion error is that it increases non-linearly
with. This behavior of the lesion error is also partially attributable to LAT, because while
much signal is removed from the lesions, some signal is added back from spill-over, as
well as from scatter and randoms. The second term in Equation 4.1 represents the effect
of spillover. Similarly, the signal in the cysts is due to mispositioned signal from spillover, in addition to scatter and randoms, which explains the loss of contrast.
The breast phantom images in Figure 3.2 visually demonstrate a loss of signal in
the background, lesions and cysts, consistent with the increasingly negative error shown
in Figure 3.1. Additionally, the images exhibited artifacts which could further affect the
quantitative accuracy. First, the bright band along the chest wall edge (top) of the FOV
(Figure 3.2) caused measurements there to be higher than farther inside the FOV. These
measurements were excluded from the results reported here. This artifact is likely due to
different dead-time in the detector modules along that edge compared to modules farther
inside the FOV. The count rate was probably lower in those modules for two reasons.
First, there was no activity outside the FOV, so there were fewer single events to induce
dead time. However, this artifact is visible in clinical images of patients’ breasts even
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though there is activity in normal tissues outside the FOV during patient scans. Second,
to a lower singles rate, detector modules near the edge of the FOV might experience
lower coincidence processing time. The modules near the edge of the FOV will detect
photons in coincidence with fewer modules in the opposing detector than will the
modules near the center. With fewer coincident prompts and decreased coincidence
processing time, the modules near the edges detect a greater fraction of LORs between
modules at the edge of the FOV, hence greater signal in this region.
Another artifact is the noise around the edges of the FOV. Relatively few events
can be detected along LORs in these two regions for different reasons. Along the top
edge, LORs which contribute signal to the topmost row of pixels are confined to a single
plane perpendicular to the detectors. This reduces the number of events which can
contribute to a voxel in that plane and increases the noise, which is amplified by
correcting for geometric efficiency. Near the left and right ends of the phantom, LORs are
not constrained to a single plane, rather the translation of the detectors results in less time
spent collecting data along each LOR. Fewer events in these two regions result in lower
sampling statistics than farther inside the FOV, hence greater noise.

Specific Aim 2: Error due to Count Rate
The phantoms used to measure the overall quantitative error were scanned
multiple times while they decayed from 0.05 μCi/cc to 0.007 μCi/cc. The background
error at each background activity was compared to the error with the lowest background
and the difference was attributed to the error introduced by count rate.
The negative error contributed by the count rate (Figure 3.4) is primarily due to
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increased dead time, which reduces the fraction of all events which are counted. The fact
that the count rate error decreases with thickness is easily explained by another source of
error, attenuation. The greater total activity in thicker phantoms was more than
compensated for by exponential attenuation, which resulted in fewer total events being
collected in thicker phantoms. Thus, dead time and error due to count rate decrease with
phantom thickness.
It is interesting that the error due to count rate in lesions is different than in the
background. This could be due in part to the fact that the count rate varies as the detectors
pass of the lesions, although the error due to count rate would be expected to increase
over the lesions due to the higher count rates. The opposite was observed which might
actually be another result of LAT. Murthy’s formulation (Equation 4.1) again can be used
to predict that the count rate error in lesions is inversely proportional to LBR. The reason
is that at least some of the signal in lesions is due to spillover from the background, and
by extension the error in the lesions depends on the error in the background. A change in
the background error due to count rate will have a relatively smaller effect on the lesions.

Specific Aim 3: Error due to Attenuation
The maximum pixel values in images of a point source scanned in air and in
gelatin were used to measure the error due to attenuation, similarly to blank and
transmission scans used for attenuation correction of conventional PET scans. The
argument for using the maximum pixel values is as follows. Blurring due to noncollinearity is on the order of 0.22% of the detector separation (Cherry, Sorenson, Phelps
2003), which is smaller than the point source (~1 mm3), even for the largest paddle
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separation on the PEM Flex scanner (0.44 mm blurring with 20 cm paddle separation).
Therefore, all true LORs can be assumed to intersect the point source. Because the point
source was smaller than a pixel (1.2 × 1.2 × 1.2 mm3), the maximum pixel value
corresponded to the approximate location of each source. Scattered photons, by
definition, will necessarily result in misplaced LORs. Only small angle scatter, which
comprises a small fraction of scatter, will contribute signal to the maximum pixel value.
Randoms can be assumed to be negligible at sufficiently low count rates so essentially no
random LORs will intersect the maximum pixel value. Thus, the maximum pixel value
would contain signal primarily due to true LORs, with minimal signal from scatter and no
signal due to randoms. Comparing the decay-corrected maximum pixel value of the point
source in gelatin to that in air is a valid way to estimate the error due to attenuation.
The error due to attenuation was negative and increased with thickness (Figure
3.5), as expected. However, the magnitude of the error was greater than the relative signal
loss expected due to narrow beam attenuation of 511 keV photons by water (Figure 3.5).
This is due to the attenuation of signal from oblique LORs, which experience longer path
lengths in the phantoms and thus more attenuation. The attenuation along the most
oblique LORs was calculated for each thickness, as described in Figure 4.1, and the
relative signal loss was plotted along with the measured data (Figure 4.2). The results
indicate that the effect attenuation has on the most oblique LORs is greater than the
measured error. This is consistent because the LORs acquired have a distribution of
angles, and most are between the direct and the most oblique LORs.
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Detector width: d = 5.5 cm

d

Signal along direct LORs: S(D) = S0e-μD
D

H

Max path length: H = (D2 + d'2)1/2; d' = 21/2d
Signal along max path length:
S(H) = S0e-μH = S0 exp[-μ(D2 + 2d2)1/2]

Figure 4.1: Path length and attenuation of oblique LORs. Both depend on angle of
incidence. The maximum path length is the hypotenuse (H) of the right triangle with
one side equal to the detector separation (D) and the base (d') equivalent to a crystal
separation of 25 in the x- and y-directions.

Error due to Attenuation

%Error

y = 100×(1 – e-μD)

Measured
Error
Narrow-beam
Signal Loss
Signal Loss
along most
Oblique
LORs

Phantom Thickness (cm)
Figure 4.2: The signal loss due to attenuation along the most oblique LORs. Also
plotted are the percent signal loss expected due to attenuation of 511 keV photons in
the given thicknesses (D) of water, and the measured error due to attenuation.
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Specific Aim 4: Error due to Scatter
The error due to scatter was investigated with images of a point source scanned
with and without cold gelatin breast phantoms on top of it. The total signal in the
reconstructed image volumes was measured and the results from Specific Aim 3 were
used to estimate the signals due to attenuation and scatter, from which the error due to
scatter was calculated.
Scatter introduced a somewhat large (23%) positive error, which is expected.
What may seem counterintuitive is that the error due to scatter was relatively independent
of phantom thickness. This may be unexpected because, as is well known, the scatter
fraction in conventional PET increases with patient size (59). The results are actually
consistent with this fact because the total signal from larger phantoms or patients
decreases due to attenuation. Thus, a constant signal due to scatter (which would yield a
constant error) would represent a greater fraction of the total signal.
The reasons scatter contributes a relatively constant signal with phantom
thickness may not be immediately obvious, but it can be explained from first principles,
as illustrated in Figure 4.3. Thicker phantoms (and patients) scatter a greater number of
photons, according to Equation 4.2.
S = 1 – exp(-σD)

4.2

where S is the total fraction of photons which are scattered, σ is the Compton
scatter coefficient (0.0956 cm-1), and D is the phantom thickness. If all of the scattered
photons were measured, the signal due to scatter would actually increase. This is not the
case, however, because the scattered photons are themselves attenuated. If one assumes
for the sake of argument that scattered photons experience the same attenuation as 511
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keV photons, then the net signal measured from scatter (Equation 4.3) can be
approximated from the product of Equation 4.2 and the exponential attenuation for the
given thickness.
S’ = exp(-μD)[1 – exp(-σD)]

4.3

where S’ is the net signal due to scattered photons which undergo attenuation, and
μ is the linear attenuation coefficient of 511 keV photons in water (0.0959 cm-1).
Equation 4.3 overestimates the net signal due to scatter because photons lose energy
when scattered (65). Thus, the linear attenuation coefficient of scattered photons is higher
than 511 keV photons (17% higher for the lower level discriminator, 350 keV).
Nevertheless, the plot of Equation 4.3 in Figure 4.3 shows that this approximation
exhibits the behavior observed. Specifically, the net signal due to scatter does not change
monotonically between 4 and 12-cm of water. This approximation is also consistent with
the measurements of Watson, Case, Bendriem, Carney, Townsend, Eberl, Meikle and
Difilippo, (59) who showed that counts due to scatter actually decrease with patient
mass, as is indicated in the figure for thicknesses corresponding to the sizes of human
patients (>24 cm).
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Relative Number of Photons

Relative Signals due to Attenuation and Scatter

Phantom Thickness (cm)
Figure 4.3: Signals due to attenuation and scatter
The sum of these measured sources of error is not equal to the total error
measured for any thickness, in the lesions or background, suggesting that other sources of
error exist. For example, the effect of LAT was observed in lesions and cysts but it was
not quantified by this work. Another source of error may be detector normalization. The
relative efficiency of a crystal pair is affected, in part, by the effective area of the crystals
and the maximum path lengths photons can travel in them, as well as shielding by
intervening crystals. All of these factors depend on crystal separation and paddle
separation, however data for detector normalization of the PEM Flex system are acquired
at only one paddle separation (15 mm). Thus, the normalization performed may not be
accurate at paddle separations other than 15 mm.
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Limitations
There are some limitations to these experiments. Perhaps the most significant is
the lack of activity outside the FOV for evaluation of the total quantitative error and
count rate. Uptake in normal tissue would contribute many singles events, leading to
increased randoms rate, as well as some scatter. This effect has been shown to decrease
lesion contrast in other PEM systems (66) by increasing the background signal,
particularly close to the chest wall edge of the FOV. The effect of activity outside the
FOV on quantitation would probably be to artificially increase the signal due to randoms
and scatter. Considering the large negative errors measured, this would have artificially
reduced the error measured in most cases, and perhaps resulted in positive total error in
the background of 4-cm phantoms with 0.065 μCi/cc. By omitting activity outside the
FOV, dead time was the dominant count rate effect which contributed to the error.
This work used lesions of one size which were confined to one height between the
detectors. However, the measured AC has been shown to vary with lesion size in addition
to breast thickness (44, 45, 53). LAT affects the error in lesions of all sizes (67) while
partial volume effects (PVE) are known to contribute to the error in small lesions (45). It
has also been shown that the mean and maximum pixel values in identical spheres are
higher near the detector face and near the chest wall edge of the FOV (45). In this work
differences in background, lesion and cyst measurements were observed near the chest
wall edge of the FOV; however, these measurements were not included in the analysis.
Future investigations into the absolute quantitative accuracy of the PEM Flex system
should include lesions of multiple sizes, at different heights between the detectors and at
various distances from the edges of the FOV.
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It is impossible to acquire images without some dead-time, so the error measured
due to count rate may have been affected by dead-time in the reference images. Perhaps a
way to compensate for this problem would be to extrapolate the total error in low activity
phantoms to a background AC. Alternatively, Monte Carlo simulations could calculate
the errors contributed by all count rate effects (dead-time, randoms and pulse pile-up.)
Since position has an impact on measurements, the location of the point source
used to evaluate attenuation and scatter may also have biased the results. Ideally, scans
could be performed with a source positioned at an arbitrary height between the detectors
to test this. If that were done, however, it would be impossible to acquire gel scans and
air scans without disturbing the source. Due to the size of the point source compared to a
pixel, partial volume effects would change if the source moved between scans,
introducing a great deal of uncertainty. Also regarding the attenuation measurements,
small-angle scatter must contribute some signal to the pixel containing the point source.
This contribution is expected to be small, but Monte Carlo simulations may be useful to
validate this assumption and corroborate these results.
It was assumed that the maximum pixel value was primarily affected by
attenuation, and that scatter contributed signal everywhere else in the image volumes. In
reality, some small angle scatter certainly contributed to the maximum pixel value,
potentially biasing the measurements of attenuation which were used in calculating the
error due to scatter. However, the results of the attenuation experiments were consistent
with what should be expected for oblique LORs, lending support to this assumption. As
with the attenuation measurements, the amount of scatter measured might have varied if
the source were at different heights between the detectors. Such measurements would be
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ideal, but removing the gelatin without disturbing the source would not be practical. If the
source were to move between corresponding gelatin and air scans, differences in PVE
could have a large impact on the attenuation measurements. Rigidly fixing the point
source in place with tape on the bottom paddles was the best way to prevent motion and
minimize differences due to PVE. Not controlling the count rate between scans is another
limitation because scatter fraction increases slightly with count rate (68). Even if the
coincidence prompt rate were kept constant (i.e. by varying the source activity), the event
rate in the detector closest to the point source would inevitably vary with the source
activity. Considering these limitations, the most accurate way to quantify the effects of
scatter and attenuation would be with Monte Carlo simulations.

Future Work
Further investigations should include scans with activity outside the FOV to
simulate the rate of randoms from uptake in normal tissue. Lesions of different sizes
should be included and they should be evaluated at multiple locations within the FOV.
The errors due to attenuation and scatter should be evaluated at multiple locations within
the FOV.
Considering the difficulties in isolating the individual sources of error, the most
accurate way to quantify the effects of count rate effects, scatter and attenuation may be
to use Monte Carlo simulations.
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Conclusions
The total quantitative error of the PEM Flex Solo II has been shown to be quite
large in the uniform background, lesions and cysts in gelatin breast phantoms of different
thicknesses. This system shares many sources of quantitative error with conventional
PET scanners, including count rate effects, attenuation and scatter. In addition, the planar
LAT reconstruction further degrades the quantitative accuracy in lesions and cysts.
The total error increases negatively with increasing phantom thickness. The error
in lesions also increases non-linearly with LBR, probably due to LAT. The effects of LAT
on lesion error are important if the ultimate goal of the PEM Flex Solo II is accurate
quantitation to facilitate diagnosis of lesions.
The overall error is greatly affected by the count rate, even at clinically relevant
background activity concentration and LBRs. The count rate error is different in lesions
and background, due to the contribution of signal to the lesions from the background;
another effect of LAT. The count rate performance of the PEM Flex scanner will need to
be thoroughly characterized and corrections for dead time and randoms will need to be
developed in order to improve the quantitative accuracy of this system.
The error due to attenuation by even small breasts is quite large, and it increases
with thickness. This error is heavily weighted by oblique LORs with longer path lengths
than direct LORs. Attenuation is clearly a substantial source of error for which
corrections need to be employed on the PEM Flex system. Monte Carlo investigations
may be necessary for developing and evaluating accurate corrections for attenuation to
account for small angle scatter, count rate effects, and location within the image volume.
The attenuation correction algorithm should be performed on projection data rather than
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image data, due to the dependence of attenuation along LORs and angle of incidence.
Scatter introduced a substantial positive error which appeared to be independent
of thickness. Corrections for scatter will be essential for the PEM Flex Solo II to be
quantitatively accurate. Monte Carlo investigations may also be necessary to evaluate and
develop corrections for scatter, for the same reasons as mentioned above.
Despite the limitations of this study, the hypothesis has been shown to be true for
most of the phantom and lesion sizes evaluated. The quantitative error in images of the
PEM Flex Solo was greater than 30% in lesions with a 5:1 LBR or greater in 4 to 12-cm
thick breast phantoms, and in lesions with a 2:1 LBR in 6 to 12-cm thick phantoms. The
total quantitative error was influence largely by the effects investigated by each specific
aim. Count rate, attenuation and scatter each contributed substantial amounts of error.
LAT was also indicated as a major source of error in lesions, but was not specifically
investigated as part of this thesis.
While this system has been used to detect early stage breast cancers with high
sensitivity and specificity, its diagnostic capabilities will be limited by its low
quantitative accuracy. Corrections for count rate, attenuation and scatter are routinely
applied in conventional PET imaging and should be adapted to the planar geometry used
by the PEM Flex Solo II. LAT, as well as other sources of error (e.g. detector
normalization), will continue to be an obstacle to accurate quantitation with this system.
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